RACHEL STOLLEY: Open Payments
NPI 1124017967 · CASTLE ROCK, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,510 in 67 payments from 25 companies in 2025. Trend: 2023 $619 · 2024 $541 · 2025 $1,510
Food & beverage: $1,510
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $277 |
| Edwards Lifesciences Corporation | 2 | $271 |
| Novo Nordisk Inc | 9 | $141 |
| PFIZER INC. | 5 | $110 |
| AstraZeneca Pharmaceuticals LP | 4 | $106 |
| Amgen Inc. | 2 | $49 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $49 |
| Electromed, Inc. | 1 | $48 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $46 |
| Exact Sciences Corporation | 2 | $46 |
Products named: SAPIEN 3 Ultra RESILIA, VRAYLAR, NURTEC ODT, UBRELVY, QULIPTA, KRYSTEXXA, SMARTVEST, CAPLYTA.
Industry payments across CO — which companies pay providers there.
